title: Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome.
abstract: Nocturnal eating/drinking syndrome secondary to neuroleptic-induced restless legs syndrome (RLS) occurred under treatment with low-dose haloperidol in a 51-year-old female schizophrenic patient. Polysomnographic investigation showed a low level of sleep efficacy, periodic leg movements, and a strict relationship between nocturnal eating episodes and non-rapid eye movement sleep. Her nocturnal eating and RLS were completely inhibited by clonazepam treatment. To our knowledge, this is the first published case of nocturnal eating/drinking syndrome secondary to neuroleptic-induced RLS.
authors.affiliation: Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, Hiroshima City, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Horiguchi
authors.forename: H
authors.initials: H
authors.lastname: Yamashita
authors.forename: S
authors.initials: S
authors.lastname: Mizuno
authors.forename: Y
authors.initials: Y
authors.lastname: Kuramoto
authors.forename: A
authors.initials: A
authors.lastname: Kagaya
authors.forename: S
authors.initials: S
authors.lastname: Yamawaki
authors.forename: Y
authors.initials: Y
authors.lastname: Inami
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D002940:Circadian Rhythm / Q000502:physiology*; D004327:Drinking Behavior / Q000502:physiology*; D005247:Feeding Behavior / Q000502:physiology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012148:Restless Legs Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D012559:Schizophrenia / Q000188:drug therapy*; D013577:Syndrome; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents